1887

Abstract

T-cell-mediated immune responses against mucosal oncogenic types of human papillomaviruses (HPV) are thought to play a role in the control of the virus infection and its associated cervical lesions. The production of interleukin-2 by T-helper (Th) cells in response to the C-terminal and N-terminal domains of the HPV-16 E2 protein was determined in 74 women with cytological evidence of premalignant cervical epithelial neoplasia who participated in a non-intervention follow-up (FU) study. Cross-sectional analysis at the end of FU showed that Th cell responses against the C-terminal domain were associated with evidence of previous or present HPV-16 infection as compared to patients with no evidence of any HPV infection (18·9% versus 0%, =0·039). Th cell responses against the N-terminal domain were not associated with evidence of HPV-16 infection. No association with disease outcome was observed with Th cell responses against either of the E2 protein domains. However, longitudinal analysis revealed that Th cell responses against the C-terminal domain frequently occur at the time of virus clearance. Whether these responses are responsible for the clearance of the virus is not known.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-9-2453
1999-09-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/9/0802453a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-9-2453&mimeType=html&fmt=ahah

References

  1. Bouvard, V., Storey, A., Pim, D. & Banks, L. ( 1994; ). Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO Journal 13, 5451-5459.
    [Google Scholar]
  2. Cripe, T. P., Haugen, T. H., Turk, J. P., Schmid, P. G., Durst, M., Gissmann, L., Roman, A. & Turek, L. P. ( 1987; ). Transcriptional regulation of the human papillomavirus type-16 E6–E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO Journal 6, 3745-3753.
    [Google Scholar]
  3. Cullen, A. P., Reid, R., Campion, M. & Lorincz, A. T. ( 1991; ). Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. Journal of Virology 65, 606-612.
    [Google Scholar]
  4. de Gruijl, T. D., Bontkes, H. J., Walboomers, J. M. M., Stukart, M. J., Doekhie, F. S., Remmink, A. J., Helmerhorst, T. J. M., Verheijen, R. H. M., Duggan-Keen, M. F., Stern, P. L., Meijer, C. J. L. M. & Scheper, R. J. ( 1998; ). Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. Cancer Research 58, 1700-1706.
    [Google Scholar]
  5. Demeret, C., Yaniv, M. & Thierry, F. ( 1994; ). The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter. Journal of Virology 68, 7075-7082.
    [Google Scholar]
  6. de Roda Husman, A.-M., Walboomers, J. M. M., Meijer, C. J. L. M., Risse, E. K. J., Schipper, M. E. I., Helmerhorst, T. J. M., Bleker, O. P., Delius, H., van den Brule, A. J. C. & Snijders, P. J. F. ( 1994; ). Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. International Journal of Cancer 56, 802-806.[CrossRef]
    [Google Scholar]
  7. de Roda Husman, A.-M., Walboomers, J. M. M., van den Brule, A. J. C., Meijer, C. J. L. M. & Snijders, P. J. F. ( 1995; ). The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. Journal of General Virology 76, 1057-1062.[CrossRef]
    [Google Scholar]
  8. Dillner, J., Lenner, P., Lehtinen, M., Eklund, C., Heino, P., Wiklund, F., Hallmans, G. & Stendahl, U. ( 1994; ). A population-based seroepidemiological study of cervical cancer. Cancer Research 54, 134-141.
    [Google Scholar]
  9. Dillner, J., Wiklund, F., Lenner, P., Eklund, C., Frederiksson-Shanazarian, V., Schiller, J. T., Hibma, M., Hallmans, G. & Stendahl, U. ( 1995; ). Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. International Journal of Cancer 60, 377-382.
    [Google Scholar]
  10. Dowhanick, J. J., McBride, A. A. & Howley, P. M. ( 1995; ). Suppression of cellular proliferation by the papillomavirus E2 protein. Journal of Virology 69, 7791-7799.
    [Google Scholar]
  11. Ham, J., Dostatni, N., Gauthier, J.-M. & Yaniv, M. ( 1991; ). The papillomavirus E2 protein: a factor with many talents. Trends in Biochemical Sciences 16, 440-444.[CrossRef]
    [Google Scholar]
  12. Kónya, J., Eklund, C., af Geijersstam, V., Yuan, F., Stuber, G. & Dillner, J. ( 1997; ). Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein. Journal of General Virology 78, 2615-2620.
    [Google Scholar]
  13. Laga, M., Icenogle, J. P., Marsela, R., Manoka, A. T., Nzila, N., Ryder, R. W., Vermund, S. H., Heyward, W. L., Nelson, A. & Reeve, W. C. ( 1992; ). Genital papillomavirus infection and cervical dysplasia. Opportunistic complications of HIV infection. International Journal of Cancer 50, 45-48.[CrossRef]
    [Google Scholar]
  14. Maitland, N. J., Conway, S., Wilkinson, N. S., Ramsdale, J., Morris, J. R., Sanders, C. M., Burns, J. E., Stern, P. L. & Wells, M. ( 1998; ). Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high grade cervical intraepithelial neoplasia. Journal of Pathology 186, 275-280.[CrossRef]
    [Google Scholar]
  15. Man, S. (1998). Human cellular immune responses against human papillomaviruses in cervical neoplasia. Expert Reviews in Molecular Medicine, txt001smc, http://www-ermm.cbcu.cam.ac.uk.
  16. Mann, V. M., de Lao, S. L., Brenes, M., Brinton, L. A., Rawls, J. A., Green, M., Reeves, W. C. & Rawls, W. E. ( 1990; ). Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Research 50, 7815-7819.
    [Google Scholar]
  17. Matsukura, T., Koi, S. & Sugase, M. ( 1989; ). Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 172, 63-72.[CrossRef]
    [Google Scholar]
  18. Morris, J. D., Crook, T., Bandara, L. R., Davies, R., LaThangue, N. B. & Vousden, K. H. ( 1993; ). Human papillomavirus type 16 E7 regulates E2F and contributes to mitogenic signalling. Oncogene 8, 893-898.
    [Google Scholar]
  19. Nardelli-Hefliger, D., Roden, R. B. S., Benyacoub, J., Sahli, R., Kraehenbuhl, J.-P., Schiller, J. T., Lachat, P., Potts, A. & De Grandi, P. ( 1997; ). Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infection and Immunity 65, 3328-3336.
    [Google Scholar]
  20. Reeves, W. C., Rawls, J. A., Green, M. & Rawls, W. E. ( 1990; ). Antibodies to human papillomavirus type 16 in patients with cervical neoplasia. Lancet 335, 551-552.
    [Google Scholar]
  21. Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M. & Kenemans, P. ( 1995; ). The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. International Journal of Cancer 61, 306-311.[CrossRef]
    [Google Scholar]
  22. Rocha-Zavaleta, L., Jordan, D., Pepper, S., Corbitt, G., Clarke, F., Maitland, N. J., Sanders, C. M., Arrand, J. R., Stern, P. L. & Stacey, S. N. ( 1997; ). Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia. British Journal of Cancer 75, 1144-1150.[CrossRef]
    [Google Scholar]
  23. Sanders, C. M., Stern, P. L. & Maitland, N. J. ( 1995; ). Characterization of human papillomavirus type 16 E2 protein and subdomains expressed in insect cells. Virology 211, 418-433.[CrossRef]
    [Google Scholar]
  24. Schafer, A., Friemann, W., Mielke, M., Schwatlander, B. & Koch, M. A. ( 1991; ). The increased frequency of cervical dysplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. American Journal of Obstetrics and Gynaecology 164, 593-599.[CrossRef]
    [Google Scholar]
  25. Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A. & zur Hausen, H. ( 1985; ). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.[CrossRef]
    [Google Scholar]
  26. Selvakumar, R., Borenstein, L. A., Lin, Y. L., Ahmed, R. & Wettstein, F. O. ( 1995; ). Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. Journal of Virology 69, 602-605.
    [Google Scholar]
  27. Slebos, R. J. C., Kessis, T. D., Chen, A. W., Han, S. M., Hedrick, L. & Cho, K. R. ( 1995; ). Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro. Virology 208, 111-120.[CrossRef]
    [Google Scholar]
  28. Tindle, R. W. ( 1996; ). Human papillomavirus vaccines for cervical cancer. Current Opinions in Immunology 8, 643-650.[CrossRef]
    [Google Scholar]
  29. Ushikai, M., Lace, M. J., Yamakawa, Y., Kono, M., Anson, J., Ishiji, T., Parkkinen, S., Wicker, N., Valentine, M. E., Davidson, I. and others ( 1994; ). Trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. Journal of Virology 68, 6655–6666.
    [Google Scholar]
  30. Yee, C., Krishnan-Hewlett, I., Baker, C. C., Schlegel, R. & Howley, P. M. ( 1985; ). Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. American Journal of Pathology 119, 361-366.
    [Google Scholar]
  31. Zinkernagel, R. M. ( 1996; ). Immunology taught by viruses. Science 271, 173-178.[CrossRef]
    [Google Scholar]
  32. Zur Hausen, H. ( 1994; ). Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In Human Pathogenic Papillomaviruses. Current Topics in Microbiology and Immunology, pp. 131-156. Edited by H. Zur Hausen. Berlin: Springer Verlag.
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-9-2453
Loading
/content/journal/jgv/10.1099/0022-1317-80-9-2453
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error